EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Strategies to Mitigate Infection Risk in Patients Receiving Complement Inhibitor Therapy

Aruna K Subramanian iD, Anuja Java, Samir K Gupta iD, Shailesh Gupta, Andrew S Bomback

Clinical Infectious Diseases · 02.09.2026 · 83 (2) · 225-233

DOI: 10.1093/cid/ciag081 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Infectious Diseases, online erschienen am 18.02.2026. Verfasst von Aruna K Subramanian und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA. Hauptthemen laut MEDLINE: Complement Inactivating Agents, Bacterial Infections. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: IDSA Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prevention of encapsulated bacterial infection is critical for safe systemic treatment with complement inhibitors. Gaps in provider awareness and practical clinical guidance remain. In this narrative review, we highlight key aspects of how the complement inhibitors’ mechanisms of action might theoretically increase the risk of infection, summarize current evidence-based recommendations, provide expert opinion to fill in the gaps in these recommendations, identify critical unanswered questions, and suggest studies to address them. Following recommendations for vaccinations and antibiotic prophylaxis are key approaches for preventing serious infections from encapsulated bacteria (especially meningococci) in patients using complement inhibitors to treat kidney or eye diseases. The duration of antibiotic prophylaxis remains a provider-dependent decision because of the lack of evidence to support more specific recommendations. Consultations with infectious disease specialists regarding local bacterial resistance/sensitivity patterns may inform the choice of agents for antibiotic prophylaxis. Patients with worrisome signs or symptoms must be promptly evaluated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Complement Inactivating AgentsBacterial InfectionsHumansAntibiotic ProphylaxisAnti-Bacterial AgentsVaccination

Stichwörter der Autor:innen

Neisseria meningitidisantibiotic prophylaxiscomplement inhibitorsencapsulated bacteriavaccination strategies

Substanzen

Complement Inactivating AgentsAnti-Bacterial Agents

Autor:innen und Institutionen

  • Division of Infectious Diseases, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.
  • Division of Nephrology, Department of Medicine, Washington University School of Medicine, St.Louis, Missouri, USA.
  • Division of Infectious Diseases, Department of Internal Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Department of Ophthalmology, Broward Health, Fort Lauderdale, Florida, USA.
  • Specialty Retina Center, Advanced Research LLC, Pompano Beach, Florida, USA.
  • Division of Nephrology, Department of Medicine, Columbia University Irving Medical Center, NewYork City, New York, USA.

ORCID-Profile: Aruna K Subramanian, Samir K Gupta

Förderung

  • IDSA Foundation

Zitieren

APA

Subramanian, A. K., Java, A., Gupta, S. K., Gupta, S., & Bomback, A. S. (2026). Strategies to Mitigate Infection Risk in Patients Receiving Complement Inhibitor Therapy. Clinical Infectious Diseases, 83(2), 225-233. https://doi.org/10.1093/cid/ciag081

Vancouver

Subramanian AK, Java A, Gupta SK, Gupta S, Bomback AS. Strategies to Mitigate Infection Risk in Patients Receiving Complement Inhibitor Therapy. Clinical Infectious Diseases. 2026;83(2):225-233. doi:10.1093/cid/ciag081

BibTeX
@article{Subramanian2026,
  author = {Subramanian, Aruna K and Java, Anuja and Gupta, Samir K and Gupta, Shailesh and Bomback, Andrew S},
  title = {Strategies to Mitigate Infection Risk in Patients Receiving Complement Inhibitor Therapy},
  journal = {Clinical Infectious Diseases},
  year = {2026},
  volume = {83},
  number = {2},
  pages = {225--233},
  doi = {10.1093/cid/ciag081}
}
Kostenlos starten →